New allergy shot trial aims to tame seasonal misery
NCT ID NCT07436234
Summary
This study is testing whether an investigational injection called AK139 can safely reduce moderate to severe seasonal allergy symptoms like sneezing and a runny nose. About 111 adults with a history of poorly controlled seasonal allergies will receive either AK139 or a placebo shot and be followed for 12 weeks. The main goal is to see if AK139 is better than a placebo at lowering daily allergy symptom scores over two weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEASONAL ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tong-Ren hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.